NCT07030257: An ongoing trial by Tasca Therapeutics
This trial is ongoing. It must report results 3 years, 8 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT07030257 |
|---|---|
| Title | A Multi-Center, Open Label, Phase 1/2 Study of CP-383, in Patients With Advanced or Metastatic Solid Tumors |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 27, 2025 |
| Completion date | Aug. 15, 2028 |
| Required reporting date | Aug. 15, 2029, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |